Results 111 to 120 of about 19,315 (197)

Investigation of Solubility Enhancement Approaches of Ticagrelor

, 2018
Ticagrelor is an orally administered antiplatelet medicine, direct-acting P2Y12-receptor antagonist. Ticagrelor binds reversibly and noncompetitively to the P2Y12 receptor at a site distinct from that of the endogenous agonist adenosine diphosphate (ADP).
Ihsan A. Mohammed, Mowafaq M. Ghareeb
core   +1 more source

Ticagrelor-Induced Prolongation of the QTc Interval

, 2019
Background. Ticagrelor has been accepted as a class I antiplatelet agent in patients undergoing percutaneous coronary angioplasty (PTCA). There have been cases reported on ticagrelor being associated with various cardiac conduction defects.
Ahmad Najmi, Gaurav Khandelwal, Balakrishnan Sadasivam, Avik Ray   +3 more
core   +1 more source

Does Ticagrelor Improve Endothelial Function?

, 2019
Ticagrelor is a P2Y 12 receptor antagonist with proven clinical benefit in patients with acute coronary syndrome. Apart from its principal antiplatelet action, pleiotropic effects have been implicated in the clinical profile of ticagrelor, including a ...
Xanthopoulou, I., Moulias, A., Alexopoulos, D.   +2 more
core  

Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study.

, 2018
OBJECTIVES The study sought to assess whether treatment with ticagrelor, as compared with prasugrel and clopidogrel, improves endothelium-dependent dilation throughout the course of the treatment and other vascular biomarkers, including systemic ...
Windecker, Stephan, Janssens, Gladys, van Leeuwen, Maarten, Ortega-Paz, Luis, Investigators, HI-TECH, Leonardi, Sergio, Gianni, Umberto, Karagiannis, Alexios, Akkerhuis, K Martijn, Brugaletta, Salvatore, van den Berge, Jan C, Ariotti, Sara, Rimoldi, Stefano F, Valgimigli, Marco   +13 more
core   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Ticagrelor Versus Clopidogrel or Aspirin in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Stroke Res Treat
Zaihan AF, Mohamad Hafiz NAH, Tong YS, Thiruchelvam K, Kow CS.   +4 more
europepmc   +1 more source

Antithrombotic Therapy in Primary and Secondary Prevention of Coronary Artery Disease. [PDF]

J Clin Med
Di Leo G, Spagnolo M, Giacoppo D, Greco A, Capodanno D.   +4 more
europepmc   +1 more source

Prevalence and predictors of dyspnea in acute coronary syndrome patients receiving ticagrelor: A prospective cohort study in Iran. [PDF]

Medicine (Baltimore)
Taherkhani M, Kord N, Taherkhani A, Shirazi N, Tavasol A.   +4 more
europepmc   +1 more source

Bentracimab for Surgical and Perioperative Bleeding: Clinical Efficacy, Emerging Safety Concerns, and Implementation Challenges (Cost, Accessibility, and Evidence Gaps). [PDF]

Cureus
Bai A, Abbas W, Baig F, Kumar D, Kumar V, Mudasir M, Kanwal A, Chaudhry H, Reimer VL.   +8 more
europepmc   +1 more source

Risk factors of bleeding in patients with atrial fibrillation undergoing percutaneous coronary intervention: an analysis from the MANJUSRI study. [PDF]

Front Cardiovasc Med
Li Y, Lu W, Wang Y, Chen L, Ma G.
europepmc   +1 more source